Release Date: 26/08/10 10:39 Summary: Half year results to 30 June 2010 Price Sensitive: Yes Download Document 421.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%